Pharmacyte Biotech Inc. Insider Trading
PMCB
Insiders bought 129K on the open market and sold nothing.
Get an email when PMCB's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jan 5 – 7 | Joshua Silverman CEO and President | Bought 3 parts | 100,000 | $0.80 average | 80K | 27% | Form 4 |
| Jan 5 – 7 | Jonathan Schechter Director | Bought 3 parts | 60,000 | $0.80 average | 48K | 45% | Form 4 |
- Jan 5 – 7Joshua SilvermanCEO and President · bought 100,000 at avg $0.8080K27% of stake
- Jan 5 – 7Jonathan SchechterDirector · bought 60,000 at avg $0.8048K45% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with PMCB
Spot a number that looks wrong? Check it in PMCB's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PMCB
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.